Literature DB >> 25419258

Development path and current status of the NANIVID: a new device for cancer cell studies.

Waseem Khan Raja1, Michael R Padgen2, James K Williams2, Frank B Gertler3, Jeffrey B Wyckoff4, John S Condeelis4, James Castracane5.   

Abstract

Cancer cells create a unique microenvironment in vivo that enables migration to distant organs. To better understand the tumor micro-environment, special tools and devices are required to monitor the interactions between different cell types and the effects of particular chemical gradients. Our study presents the design and optimization of a versatile chemotaxis device, the nano-intravital device (NANIVID), which consists of etched and bonded glass substrates that create a soluble factor reservoir. The device contains a customized hydrogel blend that is loaded with epidermal growth factor (EGF), which diffuses from the outlet to create a chemotactic gradient that can be sustained for many hours in order to attract specific cells to the device. A microelectrode array is under development for quantification of cell collection and will be incorporated into future device generations. Additionally, the NANIVID can be modified to generate gradients of other soluble factors in order to initiate controlled changes to the microenvironment including the induction of hypoxia, manipulation of extracellular matrix stiffness, etc. The focus of the article is to present the design and optimization of the device towards wide ranging applications of cancer cell dynamics in vitro and, ultimately, implantation for in vivo investigations.

Entities:  

Keywords:  3-D culture; cancer cell migration; hypoxia; impedance spectroscopy; microfabrication

Year:  2012        PMID: 25419258      PMCID: PMC4238296          DOI: 10.1117/1.JMM.11.1.013013

Source DB:  PubMed          Journal:  J Micro Nanolithogr MEMS MOEMS        ISSN: 1932-5150            Impact factor:   1.220


  34 in total

Review 1.  Hypoxia in cancer: significance and impact on clinical outcome.

Authors:  Peter Vaupel; Arnulf Mayer
Journal:  Cancer Metastasis Rev       Date:  2007-06       Impact factor: 9.264

2.  Improved agarose gel assay for quantification of growth factor-induced cell motility.

Authors:  Yoanne Mousseau; Dany Leclers; Karine Faucher-Durand; Jeanne Cook-Moreau; Anne-Sophie Lia-Baldini; Michel Rigaud; Franck G Sturtz
Journal:  Biotechniques       Date:  2007-10       Impact factor: 1.993

3.  Hypoxia inducible factor-alpha binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein.

Authors:  M E Cockman; N Masson; D R Mole; P Jaakkola; G W Chang; S C Clifford; E R Maher; C W Pugh; P J Ratcliffe; P H Maxwell
Journal:  J Biol Chem       Date:  2000-08-18       Impact factor: 5.157

4.  The collection of the motile population of cells from a living tumor.

Authors:  J B Wyckoff; J E Segall; J S Condeelis
Journal:  Cancer Res       Date:  2000-10-01       Impact factor: 12.701

Review 5.  The role of nutraceutical proteins and peptides in apoptosis, angiogenesis, and metastasis of cancer cells.

Authors:  Elvira Gonzalez de Mejia; Vermont P Dia
Journal:  Cancer Metastasis Rev       Date:  2010-09       Impact factor: 9.264

6.  Identification and testing of a gene expression signature of invasive carcinoma cells within primary mammary tumors.

Authors:  Weigang Wang; Sumanta Goswami; Kyle Lapidus; Amber L Wells; Jeffrey B Wyckoff; Erik Sahai; Robert H Singer; Jeffrey E Segall; John S Condeelis
Journal:  Cancer Res       Date:  2004-12-01       Impact factor: 12.701

7.  Hydrogel-based drug delivery systems: comparison of drug diffusivity and release kinetics.

Authors:  Ferdinand Brandl; Fritz Kastner; Ruth M Gschwind; Torsten Blunk; Jörg Tessmar; Achim Göpferich
Journal:  J Control Release       Date:  2009-11-01       Impact factor: 9.776

Review 8.  Hypoxia-driven selection of the metastatic phenotype.

Authors:  Richard Sullivan; Charles H Graham
Journal:  Cancer Metastasis Rev       Date:  2007-06       Impact factor: 9.264

9.  Effective neutrophil chemotaxis is strongly influenced by mean IL-8 concentration.

Authors:  Francis Lin; Connie Minh-Canh Nguyen; Shur-Jen Wang; Wajeeh Saadi; Steven P Gross; Noo Li Jeon
Journal:  Biochem Biophys Res Commun       Date:  2004-06-25       Impact factor: 3.575

10.  Mena deficiency delays tumor progression and decreases metastasis in polyoma middle-T transgenic mouse mammary tumors.

Authors:  Evanthia T Roussos; Yarong Wang; Jeffrey B Wyckoff; Rani S Sellers; Weigang Wang; Jiufeng Li; Jeffrey W Pollard; Frank B Gertler; John S Condeelis
Journal:  Breast Cancer Res       Date:  2010-11-25       Impact factor: 6.466

View more
  3 in total

1.  Phenotypic heterogeneity of disseminated tumour cells is preset by primary tumour hypoxic microenvironments.

Authors:  Georg Fluegen; Alvaro Avivar-Valderas; Yarong Wang; Michael R Padgen; James K Williams; Ana Rita Nobre; Veronica Calvo; Julie F Cheung; Jose Javier Bravo-Cordero; David Entenberg; James Castracane; Vladislav Verkhusha; Patricia J Keely; John Condeelis; Julio A Aguirre-Ghiso
Journal:  Nat Cell Biol       Date:  2017-01-23       Impact factor: 28.824

2.  The Tumor Microenvironment at a Turning Point Knowledge Gained Over the Last Decade, and Challenges and Opportunities Ahead: A White Paper from the NCI TME Network.

Authors:  Yves A DeClerck; Kenneth J Pienta; Elisa C Woodhouse; Dinah S Singer; Suresh Mohla
Journal:  Cancer Res       Date:  2017-02-16       Impact factor: 12.701

Review 3.  Monitoring and modulation of the tumor microenvironment for enhanced cancer modeling.

Authors:  Tristen Head; Nathaniel C Cady
Journal:  Exp Biol Med (Maywood)       Date:  2022-01-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.